Format

Send to

Choose Destination
Small GTPases. 2018 May 4;9(3):274-282. doi: 10.1080/21541248.2016.1224287. Epub 2016 Sep 20.

Myc requires RhoA/SRF to reprogram glutamine metabolism.

Author information

1
a Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology & Institute of Biomedicine, University of Helsinki , Helsinki , Finland.
2
b Research Programs Unit/Genome-Scale Biology and Department of Pathology , Haartman Institute, University of Helsinki , Helsinki , Finland.

Abstract

RhoA regulates actin cytoskeleton but recent evidence suggest a role for this conserved Rho GTPase also in other cellular processes, including transcriptional control of cell proliferation and survival. Interestingy, loss of RhoA is synthetic lethal with oncogenic Myc, a master transcription factor that turns on anabolic metabolism to promote cell growth in many cancers. We show evidence indicating that the synthetic lethal interaction between RhoA loss and Myc arises from deficiency in glutamine utilization, resulting from impaired co-regulation of glutaminase expression and anaplerosis by Myc and RhoA - serum response factor (SRF) pathway. The results suggest metabolic coordination between Myc and RhoA/SRF in sustaining cancer cell viability and indicate RhoA/SRF as a potential vulnerability in cancer cells for therapeutic targeting.

KEYWORDS:

Myc; RhoA; SRF; apoptosis; breast cancer; glutamine metabolism

PMID:
27532209
PMCID:
PMC5927483
DOI:
10.1080/21541248.2016.1224287
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center